Navigation Links
Identifying brain lesions with impaired consciousness

According to a new study it is indicative that systolic blood pressure is a good indicator for diagnosing brain lesions in patients with impaired consciousness. This means doctors may now have a better way// to estimate patients, as opposed to using expensive and time-consuming imaging technology.

Researchers studied the vital signs of 450 patients who were admitted to an emergency room with impaired consciousness. Of the patients, 221 had brain lesions that led to their condition.

The correlation of vital signs before and after brain lesion diagnosis showed that systolic blood pressure levels was more precise in the determination of brain lesions than diastolic blood pressure levels or pulse rate. Anyhow, the authors feel that compared with those patients without a lesion, those with a lesion had significantly higher systolic blood pressure, higher diastolic blood pressure, and significantly lower pulse rates.

Former studies have tried to show the cause and location of brain lesions that impaired consciousness. They have determined individual factors but have not yielded any practicable results. Brain lesions are more common in coma patients with stroke, brain tumors, epilepsy or meningitis

. The authors say, "Our study justifies the validity of systolic blood pressure for discriminating between patients with impaired consciousness who have a brain lesion and those who do not. Using systolic blood pressure in the diagnosis of impaired consciousness should give both clinical and economical benefits."


'"/>




Page: 1

Related medicine news :

1. Identifying bacteria made amiable
2. Identifying Virus Found To Be Essential for HIV Patients
3. Identifying Those At Risk For Diabetes
4. Identifying Predictors Of Anthrax
5. Identifying The Risks Of Developing Schizophrenia
6. Identifying Irregular Heart Beats
7. Identifying Those At Risk For Diabetes
8. Identifying Heart Disease Early
9. Identifying The Risk For Kidney Infection
10. Identifying What Consumers Look For On Food Stuff Labels
11. Scientists Closer To Identifying Gene Connected To Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: